Background/Aims: Skin transplantation aims to cover skin defects but often fails due to immune rejection of the transplantated tissue. Immature dendritic cells (imDCs) induce immune tolerance but have a low migration rate. After stimulation, imDCs transform into mature DCs, which activate immune rejection. Thus, inducing imDC to obtain a high migration counteracts development of immune tolerance. Methods & Results: We transfected imDCs with a recombinant adenovirus carrying the CCR7 gene (Ad-CCR7) and a small interfering RNA targeting RelB (RelB-siRNA) to concurrently overexpress CCR7 and downregulate RelB expression. Functionally, such cells showed a significantly enhanced migration rate in the chemotactic assay and decreased T-cell proliferation after lipopolysaccharide stimulation in mixed lymphocyte reactions. Cotransfected cells showed an increased ability to induce immune tolerance by upregulating T regulatory (Treg) cells and shifting the Th1/Th2 ratio. Cotransfection of Ad-CCR7 and RelB-siRNA endowed imDCs with resistance to apoptosis and cell death. CCR7 overexpression and RelB knockdown (KD) in imDCs improve skin-graft survival in a murine skin-transplantation model. Conclusion: Transfection with Ad-CCR7 and RelB KD in imDCs may be an effective approach inducing immune tolerance, thus being potentially valuable for inhibiting allograft rejection.
Concurrent

Introduction
Allogeneic skin transplantation is an early, effective method used to cover wounded areas affected by large deep burns or other forms of trauma, as well as a promising approach
Transfection of adenovirus and siRNA
The siRNA sequences used for targeting RelB or control sequences were as follows: siRNA-RelB, TGCCGAATCAACAAGGAGA; non-silencing siRNA, TTCTCCGAACGTGTCACGT; all siRNAs were synthesized and annealed by Shanghai GeneChem Limited Company (Shanghai, China). According to the manufacturer's protocol [9] , 200-pmol siRNA labeled with 5′-Cy3 was transfected when DCs were 50%-70% confluent on day 3 using GeneSilencer® Transfection Reagent (CA, USA). On day 1 after the siRNA transfection (day 4), the cells were transfected with Ad-CCR7 containing green fluorescent protein (GFP); the recombinant vector was constructed in our laboratory using standard protocols [3] . For some experiments, DCs were cultured with LPS (1 µg/mL) for 48 h on day 6 to allow for maturation. Empty adenoviral vector and scrambled siRNA were transfected as a control. Transduction efficiency was measured by the frequency of GFP-positive or red fluorescent protein (RFP)-positive cells. The nonadherent cells were harvested for detection of RelB, CCR7 protein expression by Western blotting or phenotype detection by fluorescence-activated cell sorting (FACS) at different times.
Flow cytometry
Phenotype analyses of DCs in the different conditions were evaluated by flow cytometry using the following monoclonal antibodies (mAbs): anti-mouse CD80, CD86, CCR7 (FITC; eBioscience, CA, USA). Briefly, the cells were collected, washed, and incubated at 4°C for 30 min with each mAb diluted to the optimal concentration. The appropriate isotype was used as the control mAb. The cells were subjected to flow cytometric analysis (FACS Calibur flow cytometer).
Cell-migration assay
Cell-migration assays were performed using a 24-well Transwell microplate with a 5-µm membrane pore size (Corning, New York, USA). At day 5, the different types of DCs were resuspended in migration medium (RPMI-1640 supplemented with 1% human serum, 500-U/mL GM-CSF, and 250-U/mL IL-4), and 200 μL of the cell suspension (2 × 105 cells) was added to the upper chamber. The lower chambers contained 600 μL migration medium supplemented with 300-ng/mL cCCL19 (R&D Systems, MN, USA). The chamber was then cultivated in 5% CO2 at 37°C for 4 h, following which the cells in the upper chamber were removed and migrating DCs harvested from the lower chamber were counted.
Detection of apoptosis and viability of DCs
Two days after LPS (1 µg/mL) stimulation (day 8), the cells were cultured in the starvation media (RPMI-1640 supplemented with 20-ng/mL rmGM-CSF, 10-ng/mL rmIL-4, and no serum) for 24 h to induce the apoptosis. To quantify cell viability, 100 mL of DCs were seeded (2.5 × 105 cells/mL) with starvation media in 96-well plates, and the MTT (Sangon Biotech shanghai, China) assay was performed according to manufacturer's instructions. Data are presented as cell activity relative to control samples. Alternatively, the cells were assessed by flow cytometry stained with fluorescein-isothiocytanate (FITC)-conjugated annexin V and PI, according to the manufacturer's instructions.
One-way mixed lymphocyte reaction (MLR)
One day after LPS stimulation (day 7), different types of DCs were resuspended at 1 × 105 cells/mL in RPMI-1640 for a 30-min incubation with mitomycin C (25 ng/L) and washed twice with RPMI-1640 to serve as stimulators. The nylon wool-purified splenic T cells (1 × 106 cells/mL) from BALB/c served as responders; DCs were mixed with T cells at a 1:10 ratio. The mixed cultures were established in triplicate in 96-well round-bottomed microculture plates (200 µL/well) and maintained in a complete medium for 72 h at 37°C in 5% CO2.
[3H]-TdR (1 mCi/well) was added for the final 18 h of culture. T cells cultured in medium were used as a control. Cells were harvested onto glass-fiber filter disks, and incorporation of [3H]-TdR into DNA was assessed by a Wallac 1450 liquid scintillation counter (LS 6000 TA, Beckman; Fullerton California).
Results are expressed as mean cpm ± standard deviation (SD).
TTreg-cell test
One day after LPS stimulation (day 7), different types of DCs were cocultured with nylon wool-purified splenic T cells from BALB/c; DCs were mixed with T cells at a 1:10 ratio. To examine the population of CD4 + CD25 + Tregs, cocultured cells were stained with FITC-conjugated anti-mouse CD4 antibody (10 µL) and phycoerythrin (PE)-Cy5-conjugated anti-mouse CD25 antibody (10 µL; eBioscience, San Diego, USA) according to the manufacturer's infections. In some experiments, cells were permeabilized and fixed with CytoPerm/CytoFix (BD Biosciences), further stained with anti-mouse Foxp3-PE mAb (eBioscience) and FITCconjugated anti-mouse CD4 antibody. Differentiation of Th1 and Th2 cells was confirmed by intracellular cytokine staining of IFN-γ and IL-4 upon 5 hours stimulation with 10 nM phorbol-12 myristate-13 acetate (PMA) plus 1 μM ionomycin in the presence of BD GolgiStop™ Protein Transport Inhibitor (BD Biosciences) as the protocol. The cells were incubated at 37 °C, 5 % CO2 for 4 h and then stained with CD4(eBioscience) for 30 min at 4 °C in the dark. The cells were washed again and suspended in 0.1 % saponin buffer for 20 min and incubated with anti-IFN-γ (BD Biosciences) or anti-IL-4 (BD Biosciences) for 30 min.
Western blotting
Western blotting was performed as previously described, and the membrane was immunoblotted with the following primary antibodies: mouse RelB (Cell Signaling, USA) and mouse FoxP3 (eBioscience, San Diego, CA). Signal intensity was analyzed by Image Lab™ Software Version 4.0.1 (Biorad, Hercules, CA).
Enzyme-linked immunosorbent assays (ELISAs)
One day after LPS stimulation (day 7), different types of DCs were cocultured with nylon wool-purified splenic T cells from BALB/c. After 3 days of coculture, supernatants were collected for IL-4, IL-10, IL-2, and tumor necrosis factor (TNF)-α measurement using ELISA kits (Biotech Co, Ltd., China). Serum samples were collected from the peripheral blood of all recipient mice. A volume of 100 µL of diluted serum sample (1:2,000) was used for ELISA. All samples were measured in duplicate.
Skin allograft transplantation
Eight-week-old male C57BL/6 and BALB/c mice were kept under pathogen-free conditions in the animal room of the Southwest Hospital affiliated to the Third Medical Military University. All experiments were performed according to the Animal Ethical Committee guidelines. BALB/c mice were recipients of skin transplants from donor C57BL/6 mice. Skin allograft transplant surgery was performed as previously described [9] . Recipient BALB/c mice were primed intravenously with 106 donors of the various phenotypic BMDCs from C57BL/6 3 days before grafting, maintaining a daily injection after the transplantation until the end of the experiment. Skin survival was monitored daily by visual assessment. On day 10 after transplantation, recipient mice were humanely sacrificed to examine the grafted skin. For histological analysis, samples were fixed in 4% paraformaldehyde overnight, embedded in paraffin, sectioned, and stained with hematoxylin and eosin (H&E) for light microscopy. Sections were dewaxed, dehydrated, and then stained using H&E.
Statistical analysis
The data were provided as mean ± SD Analysis of variance was used to assess the statistical significance of differences between three or more groups. Allograft survival was reported as median survival time and the percentage of skin survival was plotted using Kaplan-Meier curves.
Results
Downregulation of RelB expression and CCR7 overexpression in imDCs by cotransfection
The imDCs were transfected with the RelB-siRNA on day 3 and Ad-CCR7 was transfected with GFP on day 4. To assess the potency of gene transfection, the transfected DCs were identified on day 6 under microscope by observing green fluorescence (Ad-CCR7) and red fluorescence (RelB-siRNA). As shown in Fig. 1A , most of the imDCs in the view presented both green and red fluorescence, which indicated that both Ad-CCR7 and RelB-siRNA were transfected into the imDCs. Compared with the control group, transfection with CCR7-adenovirus or RelB-siRNA upregulated CCR7 expression before LPS treatment or downregulate RelB expression after LPS treatment, as revealed by Western blotting (Fig. 1B) . These results indicated that cotransfection of Ad-CCR7 and RelB-siRNA enhanced CCR7 expression in imDCs and simultaneously decreased RelB expression in the presence of LPS treatment. Considering that RelB will adjust CD80 and CD86 expressions, we also examined CCR7, CD80, and CD86 protein expressions on the surface of DCs by using flow cytometry. As expected, imDCs cotransfected with Ad-CCR7 and RelB-siRNA showed significantly increased CCR7 expression without LPS treatment and significantly decreased CD80 and CD86 expression with LPS stimulation (Fig. 1C) . Collectively, the results showed that CCR7 overexpression along with RelB KD in imDCs induced CCR7 overexpression without LPS treatment while maintaining a low expression of costimulatory molecules with LPS treatment. . CCR7 overexpression and downregulation of RelB expression in imDCs by cotransfection (A) imDCs were transfected with RelB-siRNA for 3 days and CCR7-Ad for 2 days. The efficiencies of the transfection were observed with GFP fluorescence (labeled Ad-CCR7) and RFP fluorescence (labeled RelB-siRNA). Nuclei were stained with DAPI (blue). Most of the imDCs were able to express GFP and RFP together. (B) Western blot analysis showed that the cotransfection of Ad-CCR7 and RelB-siRNA significantly increased the expression of CCR7 imDCs before LPS treatment and decreased RelB expression in imDCs after LPS treatment, compared with the control group. (**P < 0.01, *P < 0.05) (C) Representative quantification of the flow cytometry analysis showed the increased expression of CCR7 and decreased expression of CD80 and CD86 in imDCs with CCR7 overexpression and RelB KD compared with the control group (*P < 0.05, ***P ≤ 0.001).
CCR7 overexpression and RelB KD in imDCs obtained high migration ability and lower ability to stimulate T-cell responses
DC migration was mediated by CCR7 in the presence of CCL19. ImDCs have a low migration ability, which could affect their ability to induce immune tolerance [10] . To test the migration ability of the imDCs after transfection, we detected the migration of different types of imDCs on day 6 by the Transwell migration assay in the presence of CCL19. Compared with the control group, the results showed that cotransfection of Ad-CCR7 and RelB-siRNA remarkably increased the migration of imDCs in the presence of CCL19 (Fig. 2A) . DCs are an important type of APCs, which are essential for the initial reaction of naive T cells. To evaluate the biological modulatory capacity of RelB-siRNA on the lymphocyte proliferation response, the different types of imDCs were cocultured with T cells on day 7 to induce MLR. After 3 days, compared with the control group, cotransfection of Ad-CCR7 and RelB-siRNA significantly decreased the ability to stimulate T-cell proliferation after LPS treatment (Fig. 2B) . These results indicated that CCR7 overexpression along with RelB KD accelerated the migration ability in imDCs and concurrently inhibited the proliferation response in T cells, thus inducing immune tolerance.
CCR7 overexpression and RelB KD in imDCs induced a shift from Th1 cells toward Th2 cells
Th1/Th2 cells are two subsets of T cells, which can restrict each other's function, and are important for the induction and maintenance of immune tolerance. It is widely accepted that the cytokines secreted by the T cells shape the outcome of the immune response [11] . We detected cytokines in the supernatant of the cocultured T cells of different types of imDCs. As shown in Fig. 3A , as compared with the control group, lower amounts of IFN-γ or IL-2, but higher amounts of IL-4 or IL-10, were observed in imDCs after CCR7 overexpression and RelB KD. As expected, IL-2 or IFN-γ was released by the Th1 cells, and IL-4 or IFN-γ was released by the Th2 cells. At the same time, a lower proportion of CD4+ T cells produced IFN-γ, and an increased percentage synthesized Th2 cytokines in the T cells co-cultured with DCs previously transfected with siRNA RelB and CCR7 was observed in the flow cytometry (Fig.3C, Fig.3D ). T-bet and GATA-3 are specific transcription factors for Th1 and Th2 cells, respectively. To further support the observation , T-bet and GATA3 protein expressions were determined in the T cells cocultured with the different types of imDCs by immunoblot analysis. The results showed that T cells cocultured with imDCs transfected with Ad-CCR7 and RelB-siRNA showed a significant reduction in T-bet protein expression, whereas GATA3 protein expression was significantly upregulated (Fig. 3B) , indicating that Fig. 2 . CCR7 overexpression and RelB KD in imDCs obtained higher migration ability and a lowered ability to stimulate T-cell responses (A) In the presence of CCL19, Transwell migration assay showed that imDCs transfected with both of Ad-CCR7 and RelB-siRNA had higher migration ability. ***P < 0.001, compared with control group. (B) After LPS treatment, the different types of imDCs were cocultured with T cells isolated from BABL/C mice. T-cell proliferation was determined by 3H-thymidine uptake in the mixed lymphocytes reaction (MLR). Results showed that imDCs transfected with both Ad-CCR7 and RelB-siRNA had low abilities to stimulate T-cell proliferation. ***P < 0.001, compared with the control group.
CCR7 overexpression along with RelB KD in imDCs was able to polarize a shift from Th1 toward Th2.
CCR7 overexpression and RelB KD in imDCs induced Treg cells
Several studies have shown that costimulatory signals are necessary for the generation of the CD4 + CD25+ Treg cells, which are considered important factors in the maintenance of transplantation tolerance [12] . To determine whether imDCs with CCR7 overexpression and RelB KD are capable of enhancing preservation of CD4 + CD25+ cells, we used flow cytometry to evaluate the amount of CD4 + CD25 + Treg cells in the T cells cocultured with different types of imDCs. As expected, compared with the other groups, an elevated number of CD4 + CD25 + T-cell fractions was observed in the T cells cocultured with imDCs having CCR7 overexpression and RelB KD (Fig. 4A) . Moreover, FoxP3 is a crucial transcription factor imDCs with CCR7 overexpression and RelB KD possessed antiapoptosis and high cell migration viability. CCR7 are not only potent chemokine receptors for DC cells, but have also been shown to inhibit apoptosis and promote the survival of DCs by certain signal pathways [13] . To determine whether imDCs with CCR7 overexpression and RelB KD have antiapoptosis for long-term survival, different types of imDCs were pretreated for 24 h in starvation media with CCL19 to induce cell apoptosis (see the Materials and Methods), following which we assessed the percentage of apoptotic or dead cells by flow cytometry. As shown in Fig. 5A , the percentage of the apoptosis or cell death in the control was greater than that in the group with imDCs having CCR7 overexpression and RelB KD. Furthermore, Western blotting showed that the apoptosis marker Bcl2 increased and Bax decreased in the cotransfected imDCs (Fig. 5B) . These results indicated that CCR7 overexpression along with RelB KD protect the cells from apoptosis or death. After culturing for 24 h in starvation media, the MTT assay was used to inspect DC-cell viability. The cell viability of cotransfected imDCs was higher than that of the control (Fig. 5C ). These results confirmed that imDCs with CCR7 The results showed that cotransfection of Ad-CCR7 and RelB-siRNA significantly decreased the percentage of the apoptotic or dead imDCs compared with the control group (**P < 0.01, ***P < 0.001). (B) Western blotting results showed the decreased ratio of Bcl2 and Bax in imDCs that were cotransfected with both Ad-CCR7 and RelB-siR-NA. **P < 0.01, ***P < 0.001, compared with the control group. (C) MTT assays showed that imDCs cotransfected with Ad-CCR7 and RelB-siRNA had higher cell viability. **P < 0.01, compared with the control group. overexpression along with RelB KD have antiapoptotic ability and high cell viability, which resulted in longer survival of the imDCs, thus facilitating immune tolerance.
CCR7 overexpression and RelB KD in imDCs prolonged skin allograft survival
As CCR7 overexpression and RelB KD in imDCs were demonstrated to obtain the abilities of high migration, immune tolerance, and antiapoptosis in vitro, we further monitored their effect on skin allograft rejection in vivo. We established a murine model of skin allograft transplantation using skin grafts derived from BALB/c donors transplanted onto C57BL/6 Fig. 6 . Injection of CCR7 overexpression and RelB KD in imDCs prolonged skin allograft survival. A murine model of skin allograft transplantation was established using skin grafts derived from BALB/c donors, which were transplanted onto C57BL/6 recipients. BALB/c recipient mice were treated with injections of 1 × 10 6 of different types of DCs. (A) Statistical analysis showed that the groups injected with the imDCs transfected with Ad-CCR7 and RelB-siRNA together, thereby significantly increased survival rate of the transplanted skin grafts, as compared with the control group. (B) Statistical analysis of the hematoxylin and eosin (H&E) staining showed that the group injected with imDCs of cotransfection of Ad-CCR7 and RelB-siRNA had less substantial inflammatory-cell infiltration. *P < 0.05, **P < 0.01, compared with the control group. (C) Serum levels of IL-2, IL-4, IL-10, and IFN-γ from different mice were tested by Enzyme-linked immunosorbent assays (ELISA) on day 7 after skin transplantation. The levels of IFN-γ and IL-2 were decreased in mice injected with imDCs having CCR7 overexpression and RelB KD, and in the meanwhile the level of IL-4 and IL-10 were elevated. *P < 0.05, **P < 0.01, compared with the control group. recipients, recording wound healing, skin color, and connectivity to evaluate the survival of transplanted skin. As shown in the Fig. 6A , either CCR7 overexpression or RelB KD alone in imDCs increased graft survival, but not as much as the concurrent CCR7 overexpression and RelB KD in imDCs, which indicates that concurrent CCR7 overexpression and RelB KD in imDCs remarkably prolongs the skin survival. To histologically investigate host immune reactions, an additional 30 mice were subjected to the same transplantation procedure to obtain skin tissue slides on day 10 after transplantation. Analysis revealed that full-thickness skin grafts from the control group were infiltrated by a mass of inflammatory cells, whereas the cotransfected imDC group showed less substantial inflammatory-cell infiltration (Fig. 6B) . ELISA measurement showed that the cytokines IL-2 or IFN-γ in the peripheral blood of the recipient mice injected with imDCs with CCR7 overexpression and RelB KD were lower than that from the mice injected with the control imDCs, whereas the secretion of cytokines IL-4 or IL-10 was higher (Fig. 6C) . These results confirmed that injecting imDCs with CCR7 overexpression and RelB KD can prolong the skin allograft survival by decreasing the immune rejection, and may represent a promising method for potential therapeutic applications in skin transplantation.
Discussion
With regard to allogeneic skin transplantation, the lifespan of the transplanted graft skin may be short because of graft rejection. The rejection reaction is problematic for clinicians and causes constant difficulty during organ transplantation. Recent experimental evidence has demonstrated that gene-modified DCs have the ability to extend allograft survival beyond that which can be achieved through drug intervention or cytokine-induced Tol-DCs [14] . The induction of gene-modified Tol-DCs has been suggested as an alternative approach to alleviate immune rejection. In the present study, we transfected imDCs with Ad-CCR7 and RelB-siRNA together. As a result, we generated imDCs with CCR7 overexpression with a relatively high migration ability while maintaining a low expression of costimulatory molecules because of RelB KD, inhibiting T-cell responses and generating Treg cells, even with LPS stimulation. Furthermore, such imDCs possess antiapoptotic ability and demonstrated longer survival than other types of DCs. Finally, we also found that administration of such DCs significantly prevented allograft rejection and delayed skin allograft rejection in murine skin transplantation, suggesting the potential clinical use of gene-modified DC.
DC migration from injected sites to lymph nodes is an important requirement for effective immunization [15] . imDCs show low expression levels of costimulatory molecules, thereby laying the foundation for clinical application of imDCs in skin transplantation. However, the low CCR7 expression on DCs will affect the ability of the imDCs to induce immune tolerance [16] . In addition, it is difficult to control the environmental conditions and to guarantee that the administered DCs are in the immature stages when they reach the draining LNs. There is a great need to enhance the tolerogenic capacity of DCs and to eventually obtain DCs suitable for clinical applications. RelB plays a critical role in DC maturation and regulates the B7/ CD28 costimulatory signals, which play an important role in allograft rejection. To the best of our knowledge, the present study is the first study to demonstrate that the concurrent CCR7 overexpression and RelB KD induces tolerance in imDCs and prolong allograft survival in skin transplantation.
CCR7 is considered a key regulator of DC in trafficking from the periphery to the draining lymph node. An additional biological function of CCR7 is its involvement in the immune responses, which induces immune rejection [17] . Various recent reports have demonstrated that CCR7 facilitates DC maturation, thus enhancing T-cell priming to activate the T-cell response [18] . It was also reported CCR7 blockade led to improved graft survival in lowrisk corneal transplantation [10] . On the other hand, RelB is required for the steady-state accumulation of migratory DCs in draining LNs, and a deficiency of the alternative RelB/p52 signaling pathway was shown to decrease DC migration ability [19] . However, in the present study, we found that even the imDCs with CCR7 overexpression maintain the immature status after LPS stimulation because of the low RelB expression. Meanwhile, the RelB-siRNA also cannot affect migration ability because of CCR7 overexpression, indicating that CCR7 and RelB cannot affect each other's function.
DC apoptosis was significantly associated with immune activity. The collective apoptosis and subsequent phagocytosis of the DC apoptotic bodies has been proposed as a possible mechanism for inducing immune response [20] . After reaching the lymph node, the short survival duration of imDCs does not permit these cells to perform their function of inducing immune tolerance. However, it has also been observed that exaggerated extension of DC lifespan leads to autoimmunity disease [21] . CCR7 promotes survival in mDCs by inhibiting apoptotic hallmarks of DCs, such as loss of mitochondrial membrane potential, membrane phosphatidylserine exposure, increased membrane blebs, and nuclear changes [22] . In the present study, we also found that concurrent CCR7 overexpression and RelB KD in imDCs obtained stronger antiapoptotic ability and expired significantly less than those of the other groups. However, whether such imDCs will remain alive for a longer duration in vivo requires further study.
CD4+CD25+Foxp3 Tregs, which constitute 5%-10% of peripheral CD4+ T cells, were considered to play a central role in inducing and maintaining tolerance by suppressing T-cell responses in several animal models and in a clinical trial of transplantation [23, 24] . The therapeutic potential of Tregs, termed cellular immunotherapy, has been shown to be effective for controlling immune responses in the graft-versus-host disease. Foxp3 appears to function as a master regulator in the development and function of regulatory T cells. In animal studies, administration of Foxp3-positive T cells has been shown to lead to marked reductions in the severity of immune rejection in some disease [25] . Consistent with previous studies, we observed that treatment with cells having CCR7 overexpression and RelB KD led to an increased number of CD4 + CD25 + T cells and increased foxp3 protein levels in the CD4+ T cells. This appeared to correlate with prolonged survival of skin allografts, suggesting that such imDCs possess a ''tolerogenic'' property, and would thus be useful in the treatment of immune rejection of the skin transplantation.
imDCs also induce suppressive elements through the secretion of several cytokines to induce immune tolerance. The cytokines promote changes to the DCs in phenotype and function, thereby influencing Th-cell differentiation [26, 27] . Th1/Th2 cells are two sets of T cells and restrict each other's function, which is critical for the balance between immune tolerance and rejection. In the immune system, the Th1/Th2-cell ratio is maintained in a dynamic balance, and it has been suggested that Th1 to Th2 switching may prevent the development of organ-specific autoimmune pathologies [28] . Consistent with previous reports, in the present study, the increased percentage of Th2, Treg and decreased percentage of Th1 among total T cells was achieved by co-culture with concurrent CCR7 overexpression and RelB KD imDCs. Furthermore, the upregulated Th2-related cytokines and downregulated Th1-related cytokines were also observed in vitro and in vivo, which may be one of the mechanisms by which concurrent CCR7 overexpression and RelB KD in imDCs induced immune tolerance.
More importantly, we showed that systemic administration of DCs with CCR7 overexpression and Rel KD can prolong skin allograft survival. However, the present study did not observe long-term survival of these skin grafts, which may have been associated with poor proliferative ability of imDCs, which cause them being unable to produce lasting effects. On the other hand, siRNA transfection is transient, lasting only for 1 week. In addition, immune reactions generated by injecting the imDCs intravenously affected the graft as well as the whole organism, causing serious side effects such as graft-versus-host-disease, infections (related to immunosuppression), and wound-healing difficulties. Furthermore, the mechanisms for regulating the immune reaction are complex, and it is possible that other proteins or pathways modify DC function. The approach of jointly inducing various mechanisms working together to achieve transplantation tolerance is an important direction
